Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of quantum dots-antibody immunocomplex

A technology of immune complexes and quantum dots, applied in measurement devices, instruments, fluorescence/phosphorescence, etc., can solve the problems of increased preparation cost, different methods, low coupling rate, etc. The effect of reducing and increasing molecular weight

Active Publication Date: 2018-11-30
RES INST OF XIAN JIAOTONG UNIV & SUZHOU
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In the prior art, there are different methods for preparing quantum dot-antibody immune complexes, resulting in large differences in coupling efficiency and increased preparation costs
The current mainstream preparation method is: react with an activator first, and then combine with a specific antibody to prepare a quantum dot-antibody immune complex; however, according to the current specific preparation method, the quantum dot-antibody immune complex is even The coupling rate is generally low, which wastes raw materials and is not conducive to large-scale production, which limits its application in bioluminescence labeling

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of quantum dots-antibody immunocomplex
  • Preparation method of quantum dots-antibody immunocomplex
  • Preparation method of quantum dots-antibody immunocomplex

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035]Dissolve 5 μL of quantum dots (emission peak at 625nm±5nm, concentration 8 μM, purchased from Wuhan Jiayuan Quantum Dot Technology Development Co., Ltd.) in 500 μL, pH=5.5, 0.01M boric acid-borax buffer solution, vortex to mix Uniform 30s. Now prepare 0.01M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and 0.01M N-hydroxysulfosuccinimide (suLfo-NHS), solvent It is pH=5.5, 0.01M boric acid-borax buffer solution. Add 8 μL, 0.01M EDC to the quantum dot solution, vortex and mix, and add 40 μL, 0.01M suLfo-NHS after 5 minutes. Sonicate at 1±1°C for 30 min. After the activation is completed, take out the activation reaction solution, place it in an ultrafiltration tube (100kd), and centrifuge in a low-temperature centrifuge at a speed of 3500rpm for 5min. After completion, add 1ml, pH=8.5, 0.01M boric acid-borax to the reaction solution buffer solution, repeated centrifugation once, and removed the reaction solution. Add 7.2 μL of mouse CRP monoclonal ...

Embodiment 2

[0042] Dissolve 5 μL of quantum dots (emission peak at 625nm±5nm, concentration 8 μM, purchased from Wuhan Jiayuan Quantum Dot Technology Development Co., Ltd.) in 500 μL, pH=5.5, 0.01M boric acid-borax buffer solution, vortex to mix Uniform 30s. Now prepare 0.01M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and 0.01M N-hydroxysulfosuccinimide (suLfo-NHS), solvent It is pH=5.5, 0.01M boric acid-borax buffer solution. Add 16 μL, 0.01M EDC to the quantum dot solution, vortex and mix, add 40 μL, 0.01M suLfo-NHS after 5 min, and vortex mix. Sonicate at 1±0.5°C for 30min. After the activation is completed, take out the activation reaction solution, place it in an ultrafiltration tube (100kd), and centrifuge in a low-temperature centrifuge at a speed of 3500rpm for 5min. After completion, add 1ml, pH=8.5, 0.01M boric acid-borax to the reaction solution buffer solution, repeated centrifugation once, and removed the reaction solution. Add 7.2 μL of mouse CRP ...

Embodiment 3

[0048] Dissolve 5 μL of quantum dots (emission peak at 625nm±5nm, concentration 8 μM, purchased from Wuhan Jiayuan Quantum Dot Technology Development Co., Ltd.) in 500 μL, pH=5.5, 0.01M boric acid-borax buffer solution, vortex to mix Uniform 30s. Now prepare 0.01M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and 0.01M N-hydroxysulfosuccinimide (suLfo-NHS), solvent It is pH=5.5, 0.01M boric acid-borax buffer solution. Add 16 μL, 0.01M EDC to the quantum dot solution, vortex and mix, add 40 μL, 0.01M suLfo-NHS after 5 min, and vortex mix. Sonicate at 1±1°C for 30 min. After the activation is completed, take out the activation reaction solution, place it in an ultrafiltration tube (100kd), and centrifuge in a low-temperature centrifuge at a speed of 3500rpm for 5min. After completion, add 1ml, pH=8.5, 0.01M boric acid-borax to the reaction solution buffer solution, repeated centrifugation once, and removed the reaction solution. Add 5.2 μL of mouse CRP m...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
coupling rateaaaaaaaaaa
Login to View More

Abstract

The invention a preparation method of quantum dots-antibody immunocomplex, including the steps of: 1) performing a reaction to carboxylic-modified quantum dots with an activator at 0-10 DEG C in a buffer solution with pH value being 5-6 to obtain activated quantum dots, wherein the activator includes 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide or a thio-substance thereof; 2) performing a reaction to the activated quantum dots with an antibody at 0-10 DEG C in a buffer solution with pH value being 6-9, thus preparing the quantum dots-antibody immunocomplex. The immunocomplex has strong fluorescence intensity, bioactivity and like features and can reach about 90% in coupling rate. The preparation method is greatly improved in raw material utilizationrate and is beneficial to large-scale application.

Description

technical field [0001] The invention belongs to the field of biomarkers, and in particular relates to a preparation method of a quantum dot-antibody immune complex. Background technique [0002] Quantum dots (QDs) are semiconductor nanoparticles mainly composed of IIB-VIA elements (such as CdSe, CdTe, CdS, ZnSe, etc.) or IIIA-VIA elements (such as InP, InAs, etc.). Since the discovery of synthesis in the 1980s, due to its special fluorescence characteristics, such as: 1) size-controlled emission spectrum, adjustable color, can realize multicolor labeling of the same quantum dots; 2) wide excitation spectrum, narrow and symmetrical emission spectrum 3) Large Stokes shift; 4) High photochemical stability and resistance to photobleaching; 5) High fluorescence efficiency; 6) Good biocompatibility; 7) Long fluorescence lifetime, etc., so it can be extended to biological applications mark. [0003] At present, quantum dots are a new type of nanomaterials, and the preparation met...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/533G01N33/536G01N21/64
CPCG01N21/6428G01N33/533G01N33/536G01N2021/6432
Inventor 李嫚莉李超胡延祯
Owner RES INST OF XIAN JIAOTONG UNIV & SUZHOU
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com